Bionano Genomics Affirms FY2026 Sales Guidance of $30.000M-$33.000M vs $32.137M Est

Benzinga Newsdesk www.benzinga.com Negative 59.8%

Neg 59.8% Neu 0% Pos 0%

Bionano Genomics (NASDAQ:BNGO) affirms FY2026 sales outlook from $30.000 million-$33.000 million to $30.000 million-$33.000 million vs $32.137 million estimate.